Dosidal · Switzerland

Zoledronat Onco Labatec 4 mg/5 ml, solution à diluer pour perfusion

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:63012 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 63012
atc: M05BA08
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2013-04-16
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: M05BA08
authorisation_number: 63012
form: KOINF
holder: Labatec Pharma SA
holder_partner_nr: 1000310
it_number: 07.99.0.
name: Zoledronat Onco Labatec 4 mg/5 ml, solution à diluer pour perfusion
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
W3z1t7jCF2fAHz6__B7y0DKMikR5Q6uI8HT5IRfn5IIzfz5RsuNl1zKZW5pqJ-Jw5SJ9P03MmpvPXfpt9_kRlw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:63012 · Related records in other markets · Dosidal